Related Experiment Videos
High-frequency ventilation for acute pediatric respiratory failure
R B Rosenberg1, C W Broner, K J Peters
1Department of Pediatrics, Ohio State University, Columbus.
Insights
High-frequency ventilation (HFV) shows promise for treating pediatric acute severe respiratory failure. This rescue therapy improved patient ventilation and oxygenation, with over half surviving the critical condition.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Physiology
- Mechanical Ventilation
Background:
- Acute severe respiratory failure (ASRF) in children presents a significant clinical challenge.
- Conventional ventilation strategies may be insufficient for certain pediatric ASRF cases.
Purpose of the Study:
- To evaluate the effectiveness of high-frequency ventilation (HFV) as a treatment for pediatric patients experiencing ASRF.
- To assess HFV's impact on physiological parameters and survival rates in this patient cohort.
Main Methods:
- A post hoc analysis of retrospective and prospective data from a tertiary pediatric ICU.
- Twelve pediatric patients (4 months to 15 years) with ASRF were included.
- Patients received HFV after failing synchronized intermittent mandatory ventilation (SIMV) with positive end-expiratory pressure (PEEP) and oxygen therapy.
Main Results:
- Patients presented with severe respiratory failure, indicated by low lung compliance and high oxygenation index (OI).
- HFV therapy led to significant improvements in pH, PaCO2, PaO2, OI, and P(A-a)O2 (p < 0.05).
- Survival rate was 58% (7 out of 12 patients).
Conclusions:
- HFV may serve as a beneficial rescue therapy for pediatric patients with severe respiratory failure.
- Early application of HFV in refractory cases can improve respiratory parameters.
- Further research is warranted to establish optimal HFV protocols in pediatric critical care.
Objective:
To study the effectiveness of high-frequency ventilation (HFV) for the treatment of pediatric patients with acute severe respiratory failure.
Design:
Post hoc analysis of retrospectively and prospectively acquired data.
Setting:
Tertiary pediatric ICU.
Subjects:
Twelve patients, ages 4 months to 15 years, who developed acute severe respiratory failure from diverse causes.
Interventions:
Patients were treated with synchronized intermittent mandatory ventilation (SIMV) using moderate positive end-expiratory pressure (PEEP) and supplemental oxygen prior to HFV therapy. Ten of 12 patients required one or more medications to modulate preload, inotropy, and/or afterload. All patients were invasively monitored for arterial BP and arterial blood gases, and they were noninvasively monitored for oxygen saturation, end tidal or transcutaneous carbon dioxide, and electrocardiography.
Measurements And Main Results:
Severity of respiratory failure was reflected by median values of pH of 7.34, lung compliance of 0.41 ml/cm H2O/kg, P(A-a)O2 of 553 mm Hg, oxygenation index (OI) of 28, and ventilation index of 102. Significant improvement in pH, PaCO2, PaO2, OI, and P(A-a)O2 was demonstrated early in the course of HFV (p < 0.05). Seven of the patients (58 percent) were survivors.
Conclusions:
These data suggest that HFV may offer significant benefit as a rescue modality for patients with severe respiratory failure refractory to SIMV strategies early in the course of the disease process.